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With many variables to adjust, conventional manual forward planning for Gamma 
Knife (GK) radiosurgery is very complicated and cumbersome. The resulting plan 
quality heavily depends on planners’ skills, experiences and devoted efforts, and 
varies significantly among cases, planners, and institutions. Quality control for GK 
planning is desired to consistently provide high-quality plan to each patient. In this 
study, we proposed a quality control method for GK planning by building a database 
of high-quality GK plans. Patient anatomy was described by target volume, target 
shape complexity, and spatial relationship between target and nearby organs, which 
determine GK planning difficulty level. Plan quality was evaluated using target 
coverage, selectivity, intermediate dose spillage, maximum dose to 0.1 cc of brainstem, 
mean dose of ipsilateral cochlea, and beam-on time. When a new plan is created, a 
high-quality plan that has the most similar target volume size and shape complexity 
will be identified from the database. A model has also been built to predict the dose to 
brainstem and cochlea based on their overlap volume histograms. The identified 
reference plan and the predicted organ dose will help planners to make quality control 
decisions accordingly. To validate this method, we have built a database for vestibular 
schwannoma, which are considered to be challenging for GK planning due to the 
irregularly-shaped target and its proximity to brainstem and cochlea. Five cases were 
tested, among which one case was considered to be of high quality and four cases had 
a lower plan quality than prediction. These four cases were replanned and got 
substantially improved. Our results have demonstrated the efficacy of our proposed 
quality control method. This method may also be used as a plan quality prediction 
method to facilitate the development of automatic treatment planning for GK 
radiosurgery.  
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1 INTRODUCTION 
Gamma Knife (GK) radiosurgery is an important and safe alternative to traditional neurosurgery for 
a variety of brain disorders, such as brain tumors 1,2, arteriovenous malformations 3,4, vestibular 
schwannomas 5-7, and meningiomas 8-10. By focusing 192 narrow cobalt-60 beams on a single point, 
GK radiosurgery can eradicate the target with submillimeter accuracy while providing a rapid dose 
fall-off to spare the surrounding normal tissues 11. 
An optimal treatment plan should be created for every individual patient to ensure the best 
treatment efficacy. Currently, the most commonly used treatment planning approach for GK 
radiosurgery is manual forward planning. Planners manually determine the number and locations of 
the radiation shots, beam-on time and collimator sizes of the eight physical sectors for each shot, 
and adjust these parameters via a trial-and-error schema to achieve a good treatment plan. This 
manual forward planning is very cumbersome and challenging, due to the large number of variables 
to adjust and the vast degrees of freedom involved. For instance, as the eight sectors can be 
independently driven to one of three different collimator sizes or be blocked entirely, there are 48 
(i.e., 65,536) available beam shapes to be selected for each shot. Adding to this complexity, any 
location within the target volume can be a potential shot location. A target of large volume size will 
substantially increase the degrees of freedom and the complexity of treatment planning. With such 
large degrees of freedom involved in treatment planning, it is impossible for planners to manually 
explore the entire solution space to search for the best plan for each specific patient 12-16. Therefore, 
the resulting plan quality relies heavily on planners’ skills, experiences, and the effort devoted to 
planning, and can vary significantly from case to case, planner to planner and institution to 
institution17.  
Unlike the medical linear accelerator (linac) based radiotherapy, the dosimetry of GK 
radiosurgery is significantly affected by the target size and target shape complexity due to the 
mechanical design of GK treatment unit 18. The best achievable plan quality for each patient is 
essentially determined by his or her specific geometry. Therefore, although a few metrics, such as 
target coverage, selectivity, gradient index, dose delivered to organs at risk (OARs), and total beam-
on time (BOT), are often used for GK plan evaluation, it is very difficult to use these metrics to 
directly determine whether a plan is of good plan quality for a specific patient anatomy. For instance, 
a target with an irregular shape is prone to result in less conformal dose distribution compared to a 
target with a spherical shape. Equivalent dose conformity achieved in a treatment plan doesn’t 
necessarily translate to the same level of plan quality for different patient anatomy. Therefore, 
although provided with the values of these plan metrics, physicians still need to rely on their clinial 
judgement to decide whether to approve the current plan for treatment or try to further improve the 
plan quality. Plan quality control should be an essential component for GK radiosurgery to identify 
sub-optimal plans in order to ensure a consistently high plan quality for each individual patient. Yet, 
to our knowledge there is no plan quality control method available for GK radiosurgery, although 
significant effort has been devoted to developing quality control tools for linac-based radiotherapy 
19-22. 
In this study, we attempt to address this issue by building a database of high-quality GK 
treatment plans of the same disorder type and indexing these plans by target volume size, target 
shape complexity and the spatial relationship between the target and OARs. When a new treatment 
plan is created, a high-quality database plan that has the closest similarity to these anatomical 
parameters will be identified to serve as a reference for planners to estimate the expected plan quality 
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and make plan quality control decision accordingly. In this study, we have built a database and tested 
its efficacy for vestibular schwannoma cases, which are usually considered to be challenging for 
GK planning due to the irregularly-shaped target and its proximity to brainstem and ipsilateral 
cochlea.  
 
2 METHODS AND MATERIALS 
2.1 Patient database 
In this study, we have built a database of 22 previous patient cases, treated for vestibular 
schwannoma with GK radiosurgery with a Leksell GK ICONTM treatment unit (Elekta Instrument 
AB Stockholm, Stockholm, Sweden) at our institution from 2017-2019. All patients received a 
single fraction of 12.5 Gy, prescribed to 50% isodose level to allow higher dose within the tumor 
itself. For each patient, the original treatment plan was developed by our GK medical physicists 
using Leksell Gamma Plan (LGP) treatment planning system via manual forward planning, and 
reviewed and approved for treatment by our radiation oncologists and neurosurgeons. In order to 
build a database of high-quality GK plans for quality control purposes, after collecting and 
anonymizing these previous 22 clinical cases with IRB approval, two of our GK physicists 
replanned each case, trying to improve the original plan quality if possible. The same planning 
guidelines used in our institution to guide manual forward planning for GK radiosurgery of 
vestibular schwannoma cases were adopted to guide the re-planning as well: (1) 100% of 
prescription dose must be received by at least 99% of the target volume; (2) The maximum dose to 
0.1 cc of brainstem must not exceed 12 Gy; (3) Try to keep the mean dose of the ipsilateral cochlea 
below 4 Gy; (4) Try to maximize selectivity and minimize gradient index to spare the nearby normal 
tissues as much as possible. For each case, the best plan among the two new plans and the original 
plan was selected to construct the database. The plan variables, 3D dose distribution, MR images, 
as well as the contours of target, brainstem, ipsilateral cochlea and skull, were included in our 
database. In addition, our database contains plan quality metrics and anatomic parameters for each 
case. 
2.1.1 Plan quality metrics 
In our database, we used six metrics for plan quality evaluation, i.e., coverage, selectivity, conformal 
index at 50% isodose line (denoted as CI50), maximum dose to 0.1 cc of brainstem (denoted as 
DBS,0.1cc), mean dose of ipsilateral cochlea (denoted as DCO,mean), and BOT normalized to a same 
dose rate. The coverage, selectivity and CI50 are defined as follows: 
coverage =
𝑇𝑉∩𝑃𝐼𝑉
𝑇𝑉
. (1) 
selectivity =
𝑇𝑉∩𝑃𝐼𝑉
𝑃𝐼𝑉
, (2) 
CI50 =
𝑃𝐼𝑉𝑅𝑥/2
𝑇𝑉
. (3) 
Here, TV and PIV represent the target volume and the planning isodose volume that receives at least 
the prescription dose, respectively. 𝑃𝐼𝑉𝑅𝑥/2 represents the planning isodose volume that receives at 
least half of the prescription dose. We would like to point out that we use CI50 instead of gradient 
index, which is defined as 𝑃𝐼𝑉𝑅𝑥/2/𝑃𝐼𝑉 and used in LGP treatment planning system, because the 
gradient index was proposed to compare the dose gradient outside the target for plans of equal dose 
conformity and could not be used to directly compare plans of different conformity levels 23.  
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2.1.2 Patient anatomical parameters 
As previously mentioned, the dosimetry of GK radiosurgery is affected by the target size and target 
shape complexity due to the mechanical design of GK treatment unit. The spatial target-OAR 
relationships (e.g., the proximity of target to brainstem and the ipsilateral cochlea for vestibular 
schwannoma cases) directly affect the amount of dose delivered to the OAR. Therefore, in our 
database we describe patient-specific anatomy in terms of target volume size, target shape 
complexity, and spatial target-OAR relationship to indicate the patient-specific difficulty level of 
GK planning.  
Perimeter-area ratio (PARA) is the simplest shape index to measure the complexity of a 2D 
shape. It however varies with the shape size. For the same shape, an increase in size will cause a 
decrease in PARA. A new shape index, named SHAPE, was proposed by Patton to alleviate the size 
dependency issue of PARA by normalizing the PARA value to a standard shape of the same size 24. 
Because of the circular shape of the collimators in GK treatment unit, we selected circle as the 
standard shape, and calculated the SHAPE value of the target contour on each image slice and used 
the mean value as our metric of target shape complexity. For demonstration purposes, Fig. 1 shows 
five 2D shapes and five target contours on the top and bottom rows, respectively, with their SHAPE 
values listed below.  
In our database, we employed the overlap volume histogram (OVH) to quantify the spatial 
relationship between target and brainstem (denoted as 𝑂𝑉𝐻𝑇_𝐵𝑆 ) and that between target and 
ipsilateral cochlea (denoted as 𝑂𝑉𝐻𝑇_𝐶𝑂) 
19,25. As illustrated in Fig. 2, OVH refers to the cumulative 
OAR volumes within a certain distance from the target surface, and an effective calculation way is 
to expand (or shrink) the target by the corresponding distance and calculate the OAR volume 
overlapped with the expanded (or shrinked) target. Please note that 𝑂𝑉𝐻𝑇_𝐵𝑆 uses absolute volume 
corresponding to the dose limit of the maximum dose to 0.1cc brainstem, and 𝑂𝑉𝐻𝑇_𝐶𝑂  uses 
percentage volume corresponding to the dose limit of the mean dose to cochlea. From these OVH 
curves, we have also obtained the target expansion that results in 0.1cc overlap volume for brainstem 
(denoted as 𝑑𝐵𝑆,  where 𝑂𝑉𝐻𝑇_𝐵𝑆(𝑑𝐵𝑆) = 0.1 𝑐𝑐 ) and the expansion that results in 50% overlap 
volume for cochlea (𝑑𝐶𝑂 , where 𝑂𝑉𝐻𝑇_𝐶𝑂(𝑑𝐶𝑂) = 50%).  
 
Figure 1. SHAPE values of five 2D shapes (top row) and five target contours (bottom row). 
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Figure 2. Illustration of overlap volume histogram. 
2.2 Quality control  
The details of our current database are listed in Table 1. When a treatment plan is created for a new 
patient case, ideally, the plan with the most similar anatomical parameters will be identified and 
retrieved from the database. This identified plan will serve as a high-quality reference plan for 
planners to estimate the expected plan quality and make plan quality control decision accordingly. 
However, due to the limited cases in our current database, for some test cases we cannot find a 
reference plan that has all the anatomical parameters very close to the test case. Therefore, based on 
our GK planning experiences, in this preliminary study we use target volume size and target SHAPE 
index as our criterion to select the reference case, and set up a threshold of maximum 10% target 
size difference. The scheme that we have designed to automatically select the reference plan is 
present in Table 2.  
Table 1. Information of our initial patient database 
Disorder type Vestibular schwannoma 
Number of patient cases 22 
Tumor (target) location  
• Number of cases on the left side 11 
• Number of cases on the right side 11 
Anatomic parameters   
• Target size 0.093 cc – 2.779 cc 
• SHAPE value (target shape complexity) 2.14 – 2.69 
• Taget expansion to overlap with 0.1cc brainstem, that is,  
𝑑𝐵𝑆, where 𝑂𝑉𝐻𝑇_𝐵𝑆(𝑑𝐵𝑆) = 0.1 𝑐𝑐     
0.69 mm – 20.45 mm 
• Target expansion to overlap with half volume of ispilateral 
cochlea, that is, 𝑑𝐶𝑂 , where 𝑂𝑉𝐻𝑇_𝐶𝑂(𝑑𝐶𝑂) = 50%     
1.33 mm – 20.39 mm 
Plan metrics  
• Coverage  0.99 – 1.00 
• Selectivity  0.55 – 0.87 
• CI50 3.11 – 6.04 
• DBS,0.1cc 1.1 Gy – 12.0 Gy 
• DCO,mean 0.1 Gy – 9.9 Gy 
• BOT normalized to a dose rate of 3.534 Gy/min* 20.9 – 50.5  
*3.534Gy/min is the initial dose rate when the radiation source was installed in our GK ICONTM unit and 
commissioned. BOT normalized to this initial dose rate is shorter than BOT of the actual treatment due to 
source decay.   
 
Table 2. Our scheme to automatically identify the reference plan in the database 
Step 1. For testing case, find in the database the cases that have target size within the 10% size difference 
threshold 
 • If none within the threshold, no reference for the testing case 
 • If only one case within the threshold, it will be selected as the reference 
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 • If more than one case, go to step 2.  
Step 2. For those database cases that are within the size difference threshold, calculate the score as 
s =
|𝑣𝑜𝑙𝑡−𝑣𝑜𝑙𝑖| 𝑣𝑜𝑙𝑡⁄
1%
+
|𝑆𝐻𝐴𝑃𝐸𝑡−𝑆𝐻𝐴𝑃𝐸𝑖|
0.01
 , 
 where 𝑣𝑜𝑙𝑡 and 𝑣𝑜𝑙𝑖 denote the volume sizes for the testing case and the ith candidate reference 
case,   and 𝑆𝐻𝐴𝑃𝐸𝑡 and 𝑆𝐻𝐴𝑃𝐸𝑖 denote the SHAPE indices for the corresponding cases. 
Step 3. Select the case with smallest score as the reference case. 
With this scheme, the identified reference case may have a very different spatial target-OAR 
relationship, compared with the testing case. Hence, to roughly estimate the reasonable DBS,0.1cc and 
DCO,mean for the testing case, we have built a model between 𝑑𝐵𝑆 and DBS,0.1cc and a model between 
𝑑𝐶𝑂 and DCO,mean, which are formulated as 
𝐷𝐵𝑆,0.1𝑐𝑐(𝑑𝐵𝑆) = 𝑎1(𝑑𝐵𝑆)
𝑏1 + 𝑐1, (3) 
𝐷𝐶𝑂,𝑚𝑒𝑎𝑛(𝑑𝐶𝑂) = 𝑎2(𝑑𝐶𝑂)
𝑏2 + 𝑐2. (4) 
The curve fitting toolbox ctfool in Matlab (The Mathworks, Inc.) was employed to fit the parameters 
in these two models, using the 22 cases in our current database. The models are shown in Fig. 3. We 
would like to mention that our fitted cochlea dose model may not be very reliable when 𝑑𝐶𝑂 is bigger 
than 3.3 mm, due to the very few cases in our current database that have large 𝑑𝐶𝑂. The OVH curves 
of the testing case and the identified reference case will also be provided to planners to help them 
make quality control decisions.  
 
Figure 3. The models fitted using the database to estimate the reasonable branstem 0.1cc dose and cochlea 
mean dose, based on the target expansion distance 𝑑𝐵𝑆  and 𝑑𝐶𝑂  that results in 0.1cc brainstem overlap 
volume and 50% cochlea overlap volume, respectively.  
3 RESULTS 
In this preliminary study, we tested this plan quality control method on five cases using the built 
patient database. The information of the testing plans and the corresponding identified reference 
plans are listed in Table 3. The 𝑶𝑽𝑯𝑻_𝑩𝑺  and 𝑶𝑽𝑯𝑻_𝑪𝑶  that describe the spatial relationship 
between target and brainstem and between target and ipsilateral cochlea for each case are shown in 
the first two columns in Fig 4. The brainstem 0.1cc dose and cochlea mean dose obtained in each 
plan, as well as our fitted dose models, are shown in the last two columns in Fig 4.  
Table 3. Information of the testing cases (Ti, i=1,2,…,5) and their corresponding reference cases (Ri, i=1,2,…,5) 
identified from the patient database.   
 
target 
size (cc) 
SHAPE  
𝒅𝑩𝑺 
(mm) 
𝒅𝑪𝑶 
(mm) 
coverage selectivity CI50 
BOTn 
(min) 
DBS,0.1cc 
(Gy) 
DCO,mean 
(Gy) 
T1 0.777 2.34 9.10 2.28 1.00 0.69 4.01 61.0 2.8 4.2 
R1 0.790 2.64 2.40 1.58 1.00 0.71 3.94 43.0 7.6 8.0 
T2 0.289 2.46 6.00 2.49 1.00 0.56 5.29 41.2 2.5 3.7 
R2 0.303 2.45 9.56 1.54 1.00 0.71 4.18 31.9 2.0 6.9 
T3 0.283 2.59 10.64 2.24 0.99 0.43 7.05 42.4 1.8 4.0 
R3 0.284 2.56 8.78 2.56 0.99 0.70 5.30 23.7 1.8 3.4 
T4 2.784 2.20 1.20 3.60 1.00 0.79 3.20 52.4 10.4 5.1 
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R4 2.779 2.14 1.52 4.97 1.00 0.81 3.30 37.1 10.0 4.0 
T5 0.415 2.62 3.25 2.99 1.00 0.67 4.73 39.7 5.5 4.0 
R5 0.418 2.54 7.00 2.37 1.00 0.65 4.66 36.5 2.5 4.9 
 
 
Figure 4. The five rows are corresponding to the five testing cases T1-T5, respectively. 𝑶𝑽𝑯𝑻_𝑩𝑺  and 
𝑶𝑽𝑯𝑻_𝑪𝑶 are shown in the first two columns, with the OVH curves for the testing case in solid line and the 
curves for the reference case in dashed line. Our fitted dose model for DBS,0.1cc and DCO,mean are shown in the 
last two columns, and the doses obtained in the testing case and in the reference case are denoted by a diamond 
shape and a solid circle, respectively.  
With the anatomical parameters and the plan metrics of the identified reference plans, planners 
can estimate the expected plan quality for the testing plans and make plan quality control decisions 
accordingly. For instance, the target in testing case T1 has similar volume size but much smaller 
SHAPE index, and is relatively further away from both brainstem and cochlea, compared to the 
target in the corresponding high-quality reference plan R1. The geometry in T1 is relatively easier 
for GK planning than the geometry in R1. Compared with the much higher selectivity (i.e., 0.71) 
and shorter BOT (i.e.,  43.0 min) achieved in R1, replanning is suggested for the testing T1 case that 
has a selectivity of 0.69 and a BOT of 61.0 min in the current plan. As shown in Fig. 4, the OAR 
dose obtained in T1’s current plan agree with our fitted model, and hence expecting no big 
improvement on them in replanning. With similar target sizes and SHAPE values in T2 and R2 cases 
and reasonable OAR doses obtained in both cases, significant quality improvement is expected for 
T2 to improve the selectivity, CI50, and BOT to be comparable to those in R2. Similarly, large 
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improvement on selectivity, CI50, and BOT is also expected for T3. It is observed that the cochlea 
mean dose obtained in both T4 and R4 cases have a big deviation from our fitted dose model. This 
may be ascribed to the less reliability of our fitted model at large 𝒅𝑪𝑶 values. Nevertheless, the 
relatively higher cochlea dose obtained in T4 testing plan is consistent with its smaller distance 
between target and cochlea. With the similar target size and SHAPE values in T4 and R4 cases and 
similar dose conformity obtained, large improvement on BOT is expected for T4. The testing T5 
plan obtains similar values of coverage, selectivity, CI50 and BOT compared to the R5 plan, which 
is consistent with their similar target sizes and SHAPE values. As shown in Fig.4, OAR doses 
obtained in both cases are close to our built dose models. Hence, the T5 plan is considered to be at 
a high quality level, comparable to the quality of R5, and therefore doesn’t necessitate replanning.  
Our physicist replanned T1-4 cases according to the quality control results. The plan metrics of 
the obtained new plans are shown in Table 4. As expected by our quality control method, all the five 
replanned cases gained significant quality improvement. For all the cases except T2, the plan quality 
was improved at no cost of any of the plan metrics. For instance, better selectivity (0.74 vs. 0.69) 
and CI50 (3.82 vs. 4.01), shorter BOT (43.0 min vs. 61.0 min) and lower brainstem dose (2.6 Gy vs. 
2.8 Gy) were obtained in replanning for T1 case while achieving the same coverage and cochlea 
mean dose. For T3 case, the new plan significantly improved selectivity (0.68 vs. 0.43), CI50 (4.82 
vs. 7.05) and BOT (30.2 min vs. 42.4 min), while achieving slightly lower dose for brainstem and 
cochlea and same coverage. As shown in Fig 5, the dose conformity was improved in the new plan 
T3-re to a level comparable to that of reference plan R4. For case 4, BOT was substantially reduced 
in the new plan (from 52.4 min to 37.8 min), while achieving similar or slightly better values for 
other plan metrics. For T2 case, although the brainstem dose DBS,0.1cc  was increased from 2.5 Gy to 
3.4 Gy, it is still well below our 12 Gy dose limit. Meanwhile, both selectivity and BOT were 
improved substantially (i.e., from 0.56 and 41.2 min to 0.69 and 29.8 min).  
Table 4. Plan metrics of the new plans obtained by replanning for T1-4 cases (denoted as Ti-re, i=1,2,…,4). 
The plan metrics of the original plans listed in Table 3 are also listed here for comparison.  
 coverage selectivity CI50 
BOTn 
(min) 
DBS,0.1cc 
(Gy) 
DCO,mean 
(Gy) 
T1 1.00 0.69 4.01 61.0 2.8 4.2 
T1-re 1.00 0.74 3.82 43.0 2.6 4.2 
T2 1.00 0.56 5.29 41.2 2.5 3.7 
T2-re 1.00 0.69 5.04 29.8 3.4 3.6 
T3 0.99 0.43 7.05 42.4 1.8 4.0 
T3-re 0.99 0.68 4.82 30.2 1.3 3.6 
T4 1.00 0.79 3.20 52.4 10.4 5.2 
T4-re 1.00 0.81 3.20 37.8 10.4 4.1 
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Figure 5.  Replanning results of T3 case. (a1-2) shows a transverse slice of MR image for R3 and T3 cases, 
respectively. Contours of target, brainstem and ipsilateral cochlea are shown in red, orange and blue, 
respectively. Target regions of (a1-2) are zoomed in and shown in (b1-2), with the isodose lines of the 
prescription dose (in yellow) and half of the prescription dose (in green). In (b2), the isodose lines of the 
original T3 plan are shown in solid lines and those of the new plan T3-re are shown in dashed lines.   
 
4 CONCLUSION AND DISCUSSION 
Plan quality of GK treatment plans generated via manual forward planning can vary significantly 
from case to case, planner to planner and institution to institution. In order to consistently achieve 
high quality plans for each individual patient, we developed a novel quality control method for GK 
planning, and tested it for vestibular schwannoma cases. In this method, we have built a patient 
database of high-quality treatment plans, and used anatomical parameters, i.e., target volume size, 
SHAPE, 𝑶𝑽𝑯𝑻_𝑩𝑺 , 𝑶𝑽𝑯𝑻_𝑪𝑶 , as well as 𝒅𝑩𝑺 and 𝒅𝑪𝑶  obtained from OVH curves, to assess the 
planning difficulty level. When a treatment plan is created for a new patient case, a high-quality 
plan of similar planning difficulty level in the database is identified based on the values of the 
anatomy descriptors, and serves as a reference for planners to make quality control decisions 
accordingly. In this study, we have tested our method on five cases, among which four cases were 
found to have much worse plan quality than the corresponding reference plans and thus justified 
replanning. Distinct quality improvement has been achieved in these cases after replanning, 
demonstrating the efficacy of our quality control method.  
We would like to mention that we have attempted to extend the shape index from 2D to 3D in 
our experiments, that is, calculate the normalized surface area to volume ratio for target volume in 
relative to a sphere of the same volume size. However, it was found that this 3D shape index couldn’t 
well represent the planning difficulty level compared to the 2D shape index. This might be explained 
by two reasons. First, we have found that surface area calculation was heavily dependent on the 
various smoothness level of the contours along superior-inferior direction, caused by the variation 
in slice thickness among different cases. Surface area calculation is also sensitive to the inter-slice 
contouring variability. Hence, it is difficult to fairly compare the obtained values of the normalized 
surface area to volume ratio among cases. In contrast, the SHAPE index value averaged over slices 
make itself less sensitive to these issues. Second, in manual forward planning, planners usually place 
shots every few slices in the transverse view, which might make 2D shape complexity more 
correlated to the resulting plan quality.  
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One limitation of this study is the small amount of the high-quality GK plans in the current 
database that we have built for vestibular schwannoma cases. This is because of the low incidence 
of vestibular schwannoma compared to other brain tumors as well as the patient population in our 
institution. Another reason is the considerable amount of human effort involved to build this 
database, as every reference case needs to be replanned to ensure the high plan quality. For this 
preliminary study, we started with this database of limited cases to test the efficacy and feasibility 
of our quality control method, and it will continue to be updated with new cases. Due to the limited 
cases in the current database, for some testing cases it is possible that we cannot find a reference 
plan with all the anatomy descriptors very close to the testing case. In this study, we used target 
volume size and SHAPE index as our primary criteria to select the reference case. In addition, we 
used 𝒅𝑩𝑺  and 𝒅𝑪𝑶  obtained from OVH curves to roughly estimate the OAR doses that can be 
obtained when achieving good dose conformity level and BOT, based on our OAR dose models. 
Currently, our fitted cochlea dose model may not be very reliable at 𝒅𝑪𝑶 larger than 3.3 mm, due to 
the very few cases with large 𝒅𝑪𝑶 in our current database. This issue is expected to be gradually 
relieved as new cases are added to the database to increase its diversity.  
Another limitation of this study is that we can only estimate the achievable plan quality of a 
new case with a similar trade-off adopted in its corresponding reference case. We cannot predict its 
plan quality if a different trade-off is preferred for the new case. For instance, if the new patient has 
received an irradiation prior to this radiosurgery procedure and hence needs a much higher priority 
on reducing cochlea dose than improving target coverage and dose conformity, we cannot predict 
the plan quality at this situation. We will address this issue in our future work. One solution is to 
create a series of high-quality reference plans with different trade-offs. Another potential solution is 
to build a model among plan metrics for different anatomies to predict how much other plan metrics 
will be affected by improving one plan metric.  
Currently in linac-based radiotherapy, a great deal of effort has been devoted towards automatic 
treatment planning, such as knowledge-based auto-planning 26-28 and deep-learning auto-planning 
29,30. An important step in auto-planning is plan quality prediction to predict achievable plan quality 
to guide the auto-planning 31-33. Compared to linac-based radiotherapy, automatic treatment planning 
is even more desirable for GK radiosurgery to improve its planning efficiency, as GK radiosurgery 
is typically a one-day procedure and patients wait for the planning to be done while wearing a head 
frame. Our plan quality control method proposed in this study may also be used a plan quality 
prediction method for GK planning, facilitating the development of automatic treatment planning 
for GK radiosurgery.   
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